Hypoglycemia, defined as a dangerously low blood glucose level, is the most common limiting factor in the glycemic management of diabetes. In the acute setting, particularly the Emergency Department (ED), prompt and correct management is critical as severe hypoglycemia (Level 3) can lead to seizures, coma, permanent brain damage and death.
This article summarizes the definitions, risk stratification and a comprehensive approach to the acute management of hypoglycemia, primarily following contemporary clinical guidelines.
Hypoglycemia Definitions and Risk Stratification
Current guidelines classify hypoglycemia into three distinct levels:
| Level | Glucose Concentration | Clinical Significance |
| Level 1 | <70 mg/dL (<3.9 mmol/L) and ≥54 mg/dL (≥3.0 mmol/L) | The threshold for alerting the individual, warranting immediate carbohydrate intake. |
| Level 2 | <54 mg/dL (<3.0 mmol/L) | The threshold for neuroglycopenic symptoms (e.g., confusion, slurred speech). Requires immediate action and investigation. |
| Level 3 | Severe event characterized by altered mental and/or physical functioning that requires assistance from another person for recovery, irrespective of the glucose level. | A medical emergency. |
Individuals on insulin, sulfonylureas, or meglitinides are considered at risk for hypoglycemia. Those with a recent history of Level 2 or 3 events, impaired hypoglycemia awareness, or end-stage kidney disease are considered at high risk.
Acute Management Protocol
Hypoglycemia should be treated as an emergency, regardless of the patient’s level of consciousness. The treatment strategy depends on the patient’s ability to swallow and cooperate.
1. Conscious and Able to Swallow (Mild to Moderate Hypoglycemia)
This category includes Level 1 hypoglycemia and conscious patients with Level 2 symptoms.
| Step | Action | Rationale |
| 1. Initial Treatment (The “Rule of 15”) | Administer 15 to 20 grams of fast-acting glucose. (Pure glucose is preferred.) | Carbohydrate intake is based on pure glucose content for the fastest absorption. |
| Avoid foods high in fat and/or protein (e.g., chocolate, ice cream) as they delay glucose absorption. | ||
| 2. Re-check | Re-check blood glucose after 15 minutes. | To confirm recovery. |
| 3. Repeat | If glucose is still <70 mg/dL (<3.9 mmol/L), repeat the fast-acting carbohydrate dose. | Repeat treatment until glucose is stable. |
| 4. Follow-up Meal | Once glucose is >70 mg/dL, administer a long-acting carbohydrate snack (e.g., bread, crackers, or the next meal) to prevent recurrent hypoglycemia. | Replenishes glycogen stores and sustains blood glucose levels. |
2. Unconscious, Unable to Swallow, or Having Fits (Severe/Level 3 Hypoglycemia)
This requires immediate medical intervention via a parenteral route.
| Route/Condition | Recommended Treatment (UK Guidelines) | Key Notes |
| IV Access Established | Administer 75 mL of 20% glucose OR 150 mL of 10% glucose intravenously over 15 minutes. | Lower concentrations (10% or 20% dextrose) are preferred over 50% glucose to reduce the risk of phlebitis, tissue damage from extravasation, and rebound hyperglycemia. |
| No IV Access / Pre-Hospital | Administer 1 mg Glucagon (Intramuscularly [IM] or Subcutaneously [SC]). | Glucagon stimulates the liver to release stored glucose (glycogenolysis). It may be ineffective in patients who are severely malnourished or have consumed large amounts of alcohol. |
Post-Treatment Management and Prevention
- Glucagon Prescription: All individuals on insulin or at high risk for hypoglycemia should be prescribed glucagon (ideally ready-to-use formulations that do not require reconstitution).
- Treatment Plan Reevaluation: One or more episodes of Level 2 or 3 hypoglycemia must prompt an urgent reevaluation of the treatment plan, including consideration for de-intensifying or switching diabetes medications.
- Monitoring: Following a severe event, the patient should be monitored for 24 to 48 hours (longer if on long-acting insulin or a sulfonylurea) due to the risk of relapse. IV 5% Glucose 8 hourly is a good option or IV 10% Glucose 12 hourly if patient is suffering from heart failure or chronic kidney disease and too much fluid cannot be administered to them. Blood sugar should be monitored hourly initially and when the patient is stable, monitoring can be done 4 hourly or even 8 hourly.
- Education: The patient and their caregivers must receive structured education on prevention, recognition, and treatment of hypoglycemia.
- Technology: The use of Continuous Glucose Monitoring (CGM) is recommended for high-risk patients to help detect asymptomatic or nocturnal hypoglycemia and improve overall prevention.
Why 50 mL 50% Glucose is Avoided
The 50 mL ampoule of 50% glucose (containing 25 g of glucose) is a highly concentrated, hypertonic solution. While it delivers a large amount of glucose quickly, it is associated with significant risks and disadvantages:
- Risk of Extravasation Injury: The hypertonic nature of 50% glucose is highly irritant to veins. If the solution leaks out of the vein (extravasation) into the surrounding tissue, it can cause severe pain, local phlebitis (vein inflammation), and even tissue necrosis (death). This is a major concern, particularly when using a peripheral line.
- Risk of Rebound Hyperglycemia: The large, rapid bolus of 25 g of glucose often leads to an abrupt and excessive spike in blood glucose levels (rebound hyperglycemia), which can be difficult to manage afterward and is linked to poorer outcomes in critical illness (e.g., stroke, myocardial infarction).
- Viscosity and Administration: The solution is very viscous, making it more difficult to administer quickly through a peripheral IV line.
Recommended IV Treatment for Severe Hypoglycemia
For patients with severe hypoglycemia (unconscious, fitting, or Nil By Mouth) who require intravenous treatment, the preferred concentrations in the UK guidelines are:
| Concentration | Dose for Adults | Total Glucose | Rationale |
| 20% Glucose | 75 mL over 15 minutes | 15 g | Provides a sufficient, rapid glucose dose with a lower risk of phlebitis and rebound hyperglycemia than 50% glucose. |
| 10% Glucose | 150 mL over 15 minutes | 15 g | The safest IV concentration for peripheral lines, further minimizing the risk of extravasation. |
In summary, 50% glucose has largely been replaced by 10% or 20% glucose for the emergency treatment of severe hypoglycemia in adults, as these lower concentrations are safer and more effective at achieving stable recovery with fewer complications.
References and Further Reading
UK/NICE-Aligned Guidelines
- Joint British Diabetes Societies (JBDS) Inpatient Care Group – The Hospital Management of Hypoglycaemia in Adults with Diabetes Mellitus:
- NICE Guideline NG18: Type 1 diabetes in children and young people: diagnosis and management (2023 update):
- NICE Guideline NG28: Type 2 diabetes in adults: management (2022 update):
International and Consensus Reports
- American Diabetes Association (ADA) Standards of Care in Diabetes – Chapter 6: Glycemic Goals and Hypoglycemia.
Dr. Kunal Varma Bheecarry, MD is a GMC registered substantive Consultant Physician in the UK, specializing in Internal Medicine. With more than 15 years of experience on the clinical frontlines in both General Internal Medicine and Acute Medicine, he is passionate about translating complex medical topics, common problems and clinical guidelines into clear, actionable knowledge for healthcare professionals and patients alike. Every article is written and rigorously reviewed by him and other registered medical professionals to ensure clinical accuracy, guideline compliance, evidence-based reliability, authoritativeness and trustworthiness.
Disclaimer: All content is purely educational and does not constitute personal medical advice. It is not a substitute for professional clinical advice and readers must consult their own primary team. All views and interpretations are mine and not related to the work place.